Award
National Cancer Institute 3R15CA274189-01A1S1
Finding NEMO's Switchable MRI Signal Using Microfluidic Tumor Models
Recipient
West Virginia University
Award Amount
$106,400.00
Ceiling
$106,400.00
Awarded
August 28, 2024
Identifier
3R15CA274189-01A1S1
This NIH grant funds research to develop a novel MRI contrast agent targeting breast cancer cells, improving imaging specificity and safety, with training for undergraduate students.
Description
The project aims to develop and evaluate a novel MRI contrast agent, NEMO particles, designed to specifically target breast cancer cells and provide higher contrast in MRI imaging compared to traditional gadolinium-based agents. The research involves creating a portable apparatus for testing these agents in 3D microfluidic tumor models and in vivo in mice.